Table 3.
Time to response, duration of response and time to progression
| Total | Platinum sensitive | Platinum resistant | |
|---|---|---|---|
| Number of patients | 73 | 11 | 62 |
| Time to response (day) | |||
| Patient (%)a | 16 (21.9) | 3 (27.3) | 13 (21.0) |
| Median (range) | 54.0 (20–162) | 56.0 (54–59) | 52.0 (20–162) |
| Duration of response (day) | |||
| Patient (%)a | 16 (21.9) | 3 (27.3) | 13 (21.0) |
| Median (range) | 149.0 (56–309) | − (92–159) | 149.0 (56–309) |
| Withdrawal (%) | 11 (68.8) | 2 (66.7) | 9 (69.2) |
| Time to progression (day) | |||
| Patient (%)b | 71 (97.3) | 10 (90.9) | 61 (98.4) |
| Median (range) | 166.0 (14–358) | 159.0 (16–217) | 168.0 (14–358) |
| Withdrawal (%) | 30 (42.3) | 4 (40.0) | 26 (42.6) |
aResponder only. bExcluded two patients due to unable calculation for time to progression.